by Kevin McNerney, MD
Kevin McNerney, MD, is the first author of the article “Management practices of CAR T-cell-related inflammatory toxicities: a survey of pediatric CAR T-cell providers.” He shares in...
by ASTCT Press Release
Chicago – Feb. 16, 2026 – The American Society for Transplantation and Cellular Therapy® (ASTCT®) is pleased to announce Margaret MacMillan, MD, MSc, FRCPC, as the...
by ASTCT Press Release
The American Society for Transplantation and Cellular Therapy® (ASTCT®) presents top awards to leaders and organizations in the field of transplantation and cellular therapy at the Tandem...
by Biomedicine & Pharmacotherapy
Scientists say that aiming chimeric antigen receptor (CAR) T cells at both B7-H3 and B cell maturation antigen (BCMA), which is effective alone but still vulnerable to therapeutic resistance,...
by Blood
Observations from a mouse model of graft-versus-host disease (GVHD) shed light on the role Enterococcus faecalis plays in this complication of allogeneic hematopoietic cell transplantation...
by Nature Medicine
Researchers are encouraged by the early performance of multi-antigen T-cells in the setting of pancreatic ductal adenocarcinoma (PDAC), a cancer that has largely resisted immunotherapy.